Glider PTCA Balloon Catheter Registry

NCT ID: NCT01184352

Last Updated: 2012-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

125 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-07-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this Registry is to demonstrate the utility of the Glider PTCA Balloon Catheter for crossing during the treatment of coronary artery disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PCI patients treated with Glider Device

TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter

Intervention Type DEVICE

Percutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter

Percutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing PCI who are at least 18 years old
* PCI procedure included the use of at least one Glider PTCA Balloon Catheter
* Patient has been informed, in accordance with local requirements, that their data will be used in the Glider Registry

Exclusion Criteria

* N/A
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TriReme Medical, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carlo DiMario, MD

Role: PRINCIPAL_INVESTIGATOR

Royal Brompton & Harefield NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vivantes Klinikum Zum Friedrichshain

Berlin, , Germany

Site Status

Klinikum Coburg Herzkatheterlabor

Coburg, , Germany

Site Status

Alfried Krupp Khs

Essen, , Germany

Site Status

Elisabeth-Krankenhaus Essen Kardiologie

Essen, , Germany

Site Status

University Klinikum Muenster

Münster, , Germany

Site Status

Royal Brompton Hospital

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLR734

Identifier Type: -

Identifier Source: org_study_id